Cerevel Makes Progress, But Karuna Still One To Watch In Schizophrenia
Neuroscience Renaissance Continues
Executive Summary
Competition to bring new schizophrenia therapies to market is increasing, with the need to demonstrate side-effect improvements over existing drugs especially important.